Evidence map›Paper›PMID 23401019›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2013

Profiles of circulating endothelial cells and serum cytokines during adjuvant chemoradiation in rectal cancer patients.

C-C Lin, C-Y Liu, M-J Chen, T-E Wang, C-H Chu, H-Y Wang, S-C Shih, M-L Hsu, T-C Hsu, Y-J Chen

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00325871 completednot on this map

The Effect of Concurrent Chemoradiation on Circulating Endothelial Progenitor Cells in Colorectal Cancer

TypeobservationalSponsorMackay Memorial HospitalRan2006 to 2009Enrolled30ConditionsColorectal CancerArmsconcurrent chemoradiation
NCT02077296 completednot on this mapstarted 2014, after this paper: background citation

The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer

TypeobservationalSponsorSt. Antonius HospitalRan2014 to 2016Enrolled34ConditionsRectal Cancer
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

C-C LinDivision of Gastroenterology, Mackay Memorial Hospital, Taipei, Taiwan.
C-Y Liu
M-J Chen
T-E Wang
C-H Chu
H-Y Wang
S-C Shih
M-L Hsu
T-C Hsu
Y-J Chen
Mackay Memorial Hospital · TWMackay Medical College · TWMackay Junior College of Medicine, Nursing and Management · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis research aimed to demonstrate the correlation of circulating endothelial cells (CECs) count and serum cytokine levels with side effects and prognosis in rectal cancer patients receiving adjuvant chemoradiation.

methodsEleven patients received proctectomy, chemoradiotherapy and follow-up for 4 years. Fifty-five blood samples were taken before radiation and during the course. The quantities of CECs were estimated by flow cytometry, and serological factors were measured by ELISA.

resultsThe CEC level in patients without tumor recurrence was significantly lower than in patients with tumor recurrence (p < 0.01). The IL-6 and TGF-β1 levels exhibited a similar profile (p < 0.01). For morbidity, the mean CEC level in patients with grade 3 diarrhea was significantly greater than patients with grades 1 (p < 0.001) and 2 diarrhea (p < 0.005).

conclusionsLevels of CECs, serum IL-6, TGF-β1 and TNF-α during post-operative chemoradiation in rectal cancer patients might be candidate biomarkers for prognosis and morbidity (NCT00325871).

Indexed as

Chemoradiotherapy, AdjuvantAdenocarcinomaAdultAgedBiomarkers, TumorEndothelial CellsFemaleFlow CytometryFollow-Up StudiesHumansInterleukin-6Lymphatic MetastasisMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingBiomarkers, TumorIL6 protein, humanInterleukin-6TGFB1 protein, humanTransforming Growth Factor beta1Tumor Necrosis Factor-alphaVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID23401019
OpenAlexW1992330845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.